Pretreatment neutrophil-to-lymphocyte ratio predicts prognosis in patients with metastatic renal cell carcinoma receiving targeted therapy

Zhang Gui-Ming; Zhu Yao; Gu Wei-Jie; Zhang Hai-Liang; Shi Guo-Hai; Ye Ding-Wei

首页> 外文期刊>International journal of clinical oncology >Pretreatment neutrophil-to-lymphocyte ratio predicts prognosis in patients with metastatic renal cell carcinoma receiving targeted therapy

【24h】

Pretreatment neutrophil-to-lymphocyte ratio predicts prognosis in patients with metastatic renal cell carcinoma receiving targeted therapy

机译：治疗前中性粒细胞与淋巴细胞的比率可预测接受靶向治疗的转移性肾细胞癌患者的预后

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

摘要
著录项
相似文献
相关主题

摘要

The neutrophil-to-lymphocyte ratio (NLR) is associated with clinical outcomes of various cancers. This study aimed to evaluate whether pretreatment NLR can be used as a prognostic factor in patients with metastatic renal cell carcinoma (mRCC) receiving targeted therapy.

机译：中性粒细胞与淋巴细胞的比率（NLR）与各种癌症的临床结局有关。这项研究旨在评估在接受靶向治疗的转移性肾细胞癌（mRCC）患者中，预处理NLR是否可以用作预后因素。

著录项

来源
《International journal of clinical oncology》 |2016年第2期|共6页
作者
Zhang Gui-Ming; Zhu Yao; Gu Wei-Jie; Zhang Hai-Liang; Shi Guo-Hai; Ye Ding-Wei;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类肿瘤学;
关键词
Renal cell carcinoma; Metastasis; Targeted therapy; Neutrophil-to-lymphocyte ratio; Prognosis;

机译：肾细胞癌;转移;靶向治疗;中性粒细胞与淋巴细胞比例;预后;

相似文献

外文文献
中文文献
专利

1. Pretreatment neutrophil-to-lymphocyte ratio predicts prognosis in patients with metastatic renal cell carcinoma receiving targeted therapy [J] . Zhang Gui-Ming, Zhu Yao, Gu Wei-Jie, International journal of clinical oncology . 2016,第2期

机译：治疗前中性粒细胞与淋巴细胞的比率可预测接受靶向治疗的转移性肾细胞癌患者的预后
2. Predictive value of preoperative neutrophil-to-lymphocyte ratio in non-metastatic papillary renal cell carcinoma patients after receiving curative surgery [J] . Xiang Tu, Fan Wang, Tiancong Chang, Cancer Management and Research . 2019,第SpecaNoaA期

机译：术前非转移性乳头状肾癌患者术前嗜中性白细胞与淋巴细胞比例的预测价值
3. Pretreatment assessment of tumor enhancement on contrast-enhanced computed tomography as a potential predictor of treatment outcome in metastatic renal cell carcinoma patients receiving antiangiogenic therapy. [J] . Han KS, Jung DC, Choi HJ, Cancer: A Journal of the American Cancer Society . 2010,第10期

机译：对比增强计算机体层摄影术对肿瘤增强的治疗前评估，作为接受抗血管生成治疗的转移性肾细胞癌患者治疗结果的潜在预测指标。
4. Integration of Surgery and Systemic Therapy in the Treatment of Locally Advanced and Metastatic Renal Cell Carcinoma [C] . Christopher G. Wood Genitourinary Cancers Symposium . 2011

机译：外科和全身治疗在局部晚期和转移性肾细胞癌中的整合
5. Methodological Approaches for Conducting Claims-Based Studies in Patients Diagnosed with Metastatic Renal Cell Carcinoma [D] . Chun, Danielle S. 2021

机译：用于诊断转移性肾细胞癌的患者的基于权利要求的基于权利要求的方法论方法
6. Post-treatment neutrophil-to-lymphocyte ratio in predicting prognosis in patients with metastatic clear cell renal cell carcinoma receiving sunitinib as first line therapy [O] . Yong Hyun Park, Ja Hyeon Ku, Cheol Kwak, -1

机译：治疗后嗜中性粒细胞与淋巴细胞的比率预测以舒尼替尼为一线治疗的转移性透明细胞肾细胞癌患者的预后
7. Post-treatment neutrophil-to-lymphocyte ratio in predicting prognosis in patients with metastatic clear cell renal cell carcinoma receiving sunitinib as first line therapy [O] . Yong Park, Ja Ku, Cheol Kwak, 2014

机译：治疗后嗜中性粒细胞与淋巴细胞的比率预测以舒尼替尼为一线治疗的转移性透明细胞肾细胞癌患者的预后

Pretreatment neutrophil-to-lymphocyte ratio predicts prognosis in patients with metastatic renal cell carcinoma receiving targeted therapy

摘要

著录项

相似文献

相关主题

期刊订阅